Ranbaxy Laboratories News

Drug Administration to sort out issues related to generic drugs but the matter is likely to take long to resolve.

NEW DELHI: Riding on the back of consistent sales in emerging markets and cost cutting measures, Ranbaxy Laboratories on Monday posted a consolidated profit after tax of Rs.

Chandigarh: Punjab chief minister Parkash Singh Badal has asked Ranbaxy Laboratories Limited to prepare a comprehensive plan to undertake extensive research to study the root cause of the deadly diseases and suggest measures for their effective eradication to make Punjab, a disease-free state.

Pfizer may bid for Ranbaxy Laboratories, countering a $4.6 billion offer by Japan's Daiichi Sankyo for the Indian generic drug maker, the Business Standard newspaper said.

New Delhi After facing a slew of troubles in the US market last year, the country's largest drug maker, Ranbaxy Laboratories Ltd, in which Daiichi Sankyo of Japan has a 64% stake, is in for some rude shock in Europe.

The Gurgaon-based drug firm would market the products through its Latin America-based subsidiary, Ranbaxy Mexico SA de CV Mexico.

GURGAON: Ranbaxy Laboratories has entered into an in-licensing agreement with Medy-Tox, South Korea's Botulinum-Toxin specialised biotech venture, for the latter's cosmetic product, Neuronox.

Drug major Ranbaxy Laboratories has entered into a deal with South Korean biotech firm Medy-Tox for marketing its cosmetic product, Neuronox, in the Indian market.

TOKYO, Gurgaon, India, September 1, 2009 - Daiichi Sankyo Company Limited and Ranbaxy Laboratories Limited announced today that Terapia S.A. , a subsidiary of Ranbaxy in Romania, will market the osteoporosis medication, Evista in Romania.

With the government indicating on Monday that it would soon procure 20 million capsules of the generic antiviral drug Tamiflu in the wake of the spread of swine flu, drug makers across the country including Ranbaxy, Cipla, Hetero and Roche are bracing themselves for a hike in production of the in-demand drug.

Shares of Indian drug firms that make the generic version of Roche's Tamiflu, used to treat H1N1 flu, rose 5-19 per cent on Tuesday as the death toll from the pandemic in the country rose to ten.

Top Indian generic drugs firm Ranbaxy Laboratories, a unit of Japan's Daiichi Sankyo, reported Friday net profit soared during the second quarter, swelled by foreign exchange gains.

Ranbaxy Laboratories has received a final approval from from Health Canada, therapeutic products directorate to manufacture and market Ran-Simvastatin tablets in Canada.

Mumbai, May 31: Hyderabad-based Dr Reddy's Laboratories Ltd aims to be among the top five generic companies in the US by 2013, banking on an array of new drugs for which it is seeking permissions from American authorities.

Ranbaxy Laboratories Ltd. , heading for an annual loss and battling a U.S. ban on some of its drugs, said Chief Executive Officer Malvinder Singh quit as head of the company his family controlled for more than half a century.

Chairman and chief executive of Ranbaxy Laboratories, Malvinder Singh, has stepped down, handing more control over the generic drug maker to its Japanese owner Daiichi Sankyo.

The U.S. drug regulator is reviewing a a oecorrective actiona plan from Indiaa s Ranbaxy Laboratories Ltd.

The FDA has ordered a halt to approvals of drugs relying on data from a generic drug factory in India that was found to be falsifying data.

TOKYO & GURGAON, India - Daiichi Sankyo Co., Ltd. and Ranbaxy Laboratories Limited today announced that Mr.

New Delhi : The appreciating Indian rupee against the US dollar could help drugmaker Ranbaxy Laboratories to make forex gains of up to $300 million in the current quarter, thus helping it to come out of red.